Medicare could save millions if patients with macular degeneration switch to a $50 cancer drug that's just as effective as a $2,000 drug approved for the eye disease. But it was a long haul to get the clinical trial done to prove it.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2011/04/29/135833062/cheap-drug-beats-pricey-one-in-treating-vision-loss-in-elderly?ft=1&f=103537970
Posted
Apr 29 2011, 06:47 AM
by
NPR Blogs: Shots - Health Blog